Literature DB >> 15371414

Regulation of HAX-1 anti-apoptotic protein by Omi/HtrA2 protease during cell death.

Lucia Cilenti1, Mangala M Soundarapandian, George A Kyriazis, Valerie Stratico, Supriya Singh, Sanjeev Gupta, Joseph V Bonventre, Emad S Alnemri, Antonis S Zervos.   

Abstract

Omi/HtrA2 is a nuclear-encoded mitochondrial serine protease that has a pro-apoptotic function in mammalian cells. Upon induction of apoptosis, Omi translocates to the cytoplasm and participates in caspase-dependent apoptosis by binding and degrading inhibitor of apoptosis proteins. Omi can also initiate caspase-independent apoptosis in a process that relies entirely on its ability to function as an active protease. To investigate the mechanism of Omi-induced apoptosis, we set out to isolate novel substrates that are cleaved by this protease. We identified HS1-associated protein X-1 (HAX-1), a mitochondrial anti-apoptotic protein, as a specific Omi interactor that is cleaved by Omi both in vitro and in vivo. HAX-1 degradation follows Omi activation in cells treated with various apoptotic stimuli. Using a specific inhibitor of Omi, HAX-1 degradation is prevented and cell death is reduced. Cleavage of HAX-1 was not observed in a cell line derived from motor neuron degeneration 2 mice that carry a mutated form of Omi that affects its proteolytic activity. Degradation of HAX-1 is an early event in the apoptotic process and occurs while Omi is still confined in the mitochondria. Our results suggest that Omi has a unique pro-apoptotic function in mitochondria that involves removal of the HAX-1 anti-apoptotic protein. This function is distinct from its ability to activate caspase-dependent apoptosis in the cytoplasm by degrading inhibitor of apoptosis proteins.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15371414     DOI: 10.1074/jbc.M406006200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  55 in total

1.  Specific alterations of the HtrA2/HAX-1 ratio in the penumbra upon focal cerebral ischemia in mice.

Authors:  A Rami; A Langhagen
Journal:  Neurochem Res       Date:  2011-11-06       Impact factor: 3.996

2.  Regulation of Abro1/KIAA0157 during myocardial infarction and cell death reveals a novel cardioprotective mechanism for Lys63-specific deubiquitination.

Authors:  Lucia Cilenti; Meenakshi P Balakrishnan; Xiao-Liang Wang; Camilla Ambivero; Martin Sterlicchi; Federica del Monte; Xin L Ma; Antonis S Zervos
Journal:  J Mol Cell Cardiol       Date:  2010-12-30       Impact factor: 5.000

3.  Human immunodeficiency virus type 1 Vpr interacts with antiapoptotic mitochondrial protein HAX-1.

Authors:  Venkat S R K Yedavalli; Hsiu-Ming Shih; Yu-Ping Chiang; Chun-Yi Lu; Luan-Yin Chang; Mao-Yuan Chen; Che-Yen Chuang; Andrew I Dayton; Kuan-Teh Jeang; Li-Min Huang
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

Review 4.  HTRA proteases: regulated proteolysis in protein quality control.

Authors:  Tim Clausen; Markus Kaiser; Robert Huber; Michael Ehrmann
Journal:  Nat Rev Mol Cell Biol       Date:  2011-02-16       Impact factor: 94.444

Review 5.  Oxidative stress-induced signaling pathways implicated in the pathogenesis of Parkinson's disease.

Authors:  Georgia S Gaki; Athanasios G Papavassiliou
Journal:  Neuromolecular Med       Date:  2014-02-13       Impact factor: 3.843

Review 6.  Genetic heterogeneity in severe congenital neutropenia: how many aberrant pathways can kill a neutrophil?

Authors:  Alejandro A Schäffer; Christoph Klein
Journal:  Curr Opin Allergy Clin Immunol       Date:  2007-12

Review 7.  Kostmann's Disease and HCLS1-Associated Protein X-1 (HAX1).

Authors:  Christoph Klein
Journal:  J Clin Immunol       Date:  2016-12-10       Impact factor: 8.317

8.  HAX-1 overexpression, splicing and cellular localization in tumors.

Authors:  Alicja Trebinska; Alina Rembiszewska; Karolina Ciosek; Konrad Ptaszynski; Sebastian Rowinski; Jolanta Kupryjanczyk; Janusz A Siedlecki; Ewa A Grzybowska
Journal:  BMC Cancer       Date:  2010-03-02       Impact factor: 4.430

9.  Novel mitochondrial substrates of omi indicate a new regulatory role in neurodegenerative disorders.

Authors:  Felicity Johnson; Michael G Kaplitt
Journal:  PLoS One       Date:  2009-09-18       Impact factor: 3.240

10.  Distant homologs of anti-apoptotic factor HAX1 encode parvalbumin-like calcium binding proteins.

Authors:  Katarzyna Kokoszyńska; Leszek Rychlewski; Lucjan S Wyrwicz
Journal:  BMC Res Notes       Date:  2010-07-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.